Bioimpact Capital Llc

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Cullinan Oncology, Inc.
CGEM
$130.33M13.277.65M0%+$021.09
Werewolf Therapeutics, Inc.
HOWL
$15.47M5.52.39M0%+$02.51
Sutro Biopharma, Inc.
STRO
$23.15M5.014.1MNew+$23.15M3.75
iTeos Therapeutics, Inc.
ITOS
$23.81M4.831.75M0%+$03.86
Repare Therapeutics Inc.
RPTX
$7.72M3.861.64M0%+$01.25
Olema Pharmaceuticals, Inc.
OLMA
$22.12M3.491.95M+5.2%+$1.09M3.58
Xeris Biopharma Holdings, Inc.
XERS
$9.21M2.814.17M+8.3%+$705,573.431.49
ALX Oncology Holdings Inc.
ALXO
$14.14M2.441.27M+0.29%+$41,388.802.29
Zentalis Pharmaceuticals, Inc.
ZNTL
$23.9M2.131.52MNew+$23.9M3.87
Adaptimmune Therapeutics plc
ADAP
$8.05M1.995.1M0%+$01.3
Trevi Therapeutics, Inc.
TRVI
$4.63M1.91.34MNew+$4.63M0.75
Fulcrum Therapeutics, Inc.
FULC
$10.73M1.831.14MNew+$10.73M1.74
KalVista Pharmaceuticals, Inc.
KALV
$9.02M1.8760,722New+$9.02M1.46
Geron Corporation
GERN
$34.57M1.7710.48M-2.24%-$791,818.515.6
Compass Therapeutics, Inc.
CMPX
$3.9M1.431.97MNew+$3.9M0.63
REGENXBIO Inc.
RGNX
$11.57M1.12549,0780%+$01.87
89bio, Inc.
ETNB
$11.26M0.98967,742New+$11.26M1.82
Viridian Therapeutics, Inc.
VRDN
$10.75M0.96614,010+514.01%+$9M1.74
Avadel Pharmaceuticals plc
AVDL
$14.71M0.91871,149+31%+$3.48M2.38
Iovance Biotherapeutics, Inc.
IOVA
$32.6M0.792.2M-33.12%-$16.15M5.28
Verve Therapeutics, Inc.
VERV
$8.47M0.76638,1630%+$01.37
Morphic Holding, Inc.
MORF
$11.45M0.65325,333+0.49%+$56,003.201.85
Relay Therapeutics, Inc.
RLAY
$6.91M0.63832,0170%+$01.12
Crinetics Pharmaceuticals, Inc.
CRNX
$22.5M0.61480,588+0.49%+$110,190.743.64
Akero Therapeutics, Inc.
AKRO
$8.41M0.48332,924New+$8.41M1.36
Edgewise Therapeutics, Inc.
EWTX
$8.05M0.47441,259New+$8.05M1.3
MoonLake Immunotherapeutics
MLTX
$14.87M0.46296,050+0.5%+$74,039.022.41
Intellia Therapeutics, Inc.
NTLA
$11.9M0.45432,598+13.07%+$1.38M1.93
Disc Medicine, Inc.
IRON
$6.9M0.45110,779+121.56%+$3.78M1.12
Insmed Incorporated
INSM
$14.4M0.36530,794+0.5%+$71,731.722.33
Ultragenyx Pharmaceutical Inc.
RARE
$11.47M0.3245,590New+$11.47M1.86
Madrigal Pharmaceuticals, Inc.
MDGL
$16.4M0.2961,399+50.08%+$5.47M2.65
Amicus Therapeutics, Inc.
FOLD
$8.47M0.24718,970+0.43%+$36,364.861.37
Axsome Therapeutics, Inc.
AXSM
$9.11M0.24114,127+22.21%+$1.66M1.47
Revolution Medicines, Inc.
RVMD
$8.81M0.17273,217-0.07%-$6,155.931.43
Natera, Inc.
NTRA
$15.77M0.14172,413New+$15.77M2.55
Viking Therapeutics, Inc.
VKTX
$12.3M0.14150,000-53.89%-$14.37M1.99